CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Adaptimmune against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other CancersIMMATICS BIOTECHNOLOGIESJun 25, 2020

Explore Adaptimmune's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 2, 2024Lentiviral Transduction Methods1
Jul 19, 2023Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility Complex3
Jun 14, 2023T Cell Receptors1
Oct 19, 2022Vectors For Transgene Expression1
Jun 12, 2019Tcr Libraries1
Feb 13, 2019Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility Complex3

Top competitors of Adaptimmune

List of top competitors of Adaptimmune based on patent oppositions.